SEC Form 4 · accession 0001214659-16-012180
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Craig Thompson
Officer — President & COO
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 7:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $3.52 | Jun 9, 2016 | A | 170,000 | A | — | Jun 9, 2026 | Common Stock | 170,000 | 170,000 | D |
Explanation of responses
- F1The option shall vest and become exercisable, if at all, in installments upon the achievement of certain performance milestones as approved by the Company's Board of Directors.